Cargando…
Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action
Fibrotic diseases cover a spectrum of systemic and organ-specific maladies that affect a large portion of the population, currently without cure. The shared characteristic these diseases feature is their uncontrollable fibrogenesis deemed responsible for the accumulated damage in the susceptible tis...
Autores principales: | Karatzas, Evangelos, Kakouri, Andrea C., Kolios, George, Delis, Alex, Spyrou, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026018/ https://www.ncbi.nlm.nih.gov/pubmed/33826640 http://dx.doi.org/10.1371/journal.pone.0249687 |
Ejemplares similares
-
A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria
por: Karatzas, Evangelos, et al.
Publicado: (2019) -
Analyzing Gene Expression Profiles from Ataxia and Spasticity Phenotypes to Reveal Spastic Ataxia Related Pathways
por: Kakouri, Andrea C., et al.
Publicado: (2020) -
Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
por: Karatzas, E., et al.
Publicado: (2017) -
PathWalks: identifying pathway communities using a disease-related map of integrated information
por: Karatzas, Evangelos, et al.
Publicado: (2020) -
Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
por: Tomazou, Marios, et al.
Publicado: (2021)